James M Perrin1, Joan Rosenbaum Asarnow2, Terry Stancin3, Stephen P Melek4, Gregory K Fritz5. 1. Department of Pediatrics (JM Perrin), MassGeneral Hospital for Children, Harvard Medical School, Boston, Mass. Electronic address: jperrin@partners.org. 2. Department of Psychiatry and Biobehavioral Sciences (JR Asarnow), David Geffen School of Medicine, University of California Los Angeles. 3. MetroHealth Medical Center (T Stancin), Cleveland, Ohio. 4. Milliman, Inc (SP Melek), Denver, Colo. 5. Division of Child and Adolescent Psychiatry, Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, and Bradley Hasbro Children's Research Center (GK Fritz), Providence, RI.
Abstract
OBJECTIVE: To estimate additional payments associated with co-existing mental health or substance use disorders (MH/SUDs) among commercially insured children and youth with chronic medical conditions (CMCs) and to determine whether children's MH/SUDs have similar associations with parental health care payments. METHODS: Cross-sectional analysis of a national database of paid commercial insurance claims for 2012-2013. Participants were children and youth ages 0 to 26 years covered as dependents on parents' health insurance and categorized by the presence or absence of any of 11 chronic medical conditions and MH/SUDs. We determined the numbers of children and youth with CMCs and paid health care claims categorized as hospital, professional, and pharmacy services and as medical or behavioral. We compared paid claims for children and youth with CMCs with and without co-occurring MH/SUDs and for their parents. RESULTS: The sample included almost 6.6 million children and youth and 5.8 million parents. Compared to children without CMCs, children with CMCs had higher costs, even higher for children with CMCs who also had MH/SUDs. Children with CMCs and co-occurring MH/SUDs had 2.4 times the annual payments of those with chronic conditions alone, especially for medical expenses. Estimated additional annual payments associated with MH/SUDs in children with CMCs were $8.8 billion. Parents of children with CMCs and associated MH/SUDs had payments 59% higher than those for parents of children with CMCs alone. CONCLUSIONS: MH/SUDs in children and youth with CMCs are associated with higher total health care payments for both patients and their parents, suggesting potential benefits from preventing or reducing the impact of MH/SUDs among children and youth with CMCs.
OBJECTIVE: To estimate additional payments associated with co-existing mental health or substance use disorders (MH/SUDs) among commercially insured children and youth with chronic medical conditions (CMCs) and to determine whether children's MH/SUDs have similar associations with parental health care payments. METHODS: Cross-sectional analysis of a national database of paid commercial insurance claims for 2012-2013. Participants were children and youth ages 0 to 26 years covered as dependents on parents' health insurance and categorized by the presence or absence of any of 11 chronic medical conditions and MH/SUDs. We determined the numbers of children and youth with CMCs and paid health care claims categorized as hospital, professional, and pharmacy services and as medical or behavioral. We compared paid claims for children and youth with CMCs with and without co-occurring MH/SUDs and for their parents. RESULTS: The sample included almost 6.6 million children and youth and 5.8 million parents. Compared to children without CMCs, children with CMCs had higher costs, even higher for children with CMCs who also had MH/SUDs. Children with CMCs and co-occurring MH/SUDs had 2.4 times the annual payments of those with chronic conditions alone, especially for medical expenses. Estimated additional annual payments associated with MH/SUDs in children with CMCs were $8.8 billion. Parents of children with CMCs and associated MH/SUDs had payments 59% higher than those for parents of children with CMCs alone. CONCLUSIONS: MH/SUDs in children and youth with CMCs are associated with higher total health care payments for both patients and their parents, suggesting potential benefits from preventing or reducing the impact of MH/SUDs among children and youth with CMCs.
Authors: Raghav Ramachandran; Michael J McShea; Stephanie N Howson; Howard S Burkom; Hsien-Yen Chang; Jonathan P Weiner; Hadi Kharrazi Journal: JMIR Med Inform Date: 2021-11-25
Authors: Harrison Clarke; Walter Morris; Matteo Catanzano; Sophie Bennett; Anna E Coughtrey; Isobel Heyman; Holan Liang; Roz Shafran; Neha Batura Journal: BMC Health Serv Res Date: 2022-04-19 Impact factor: 2.908
Authors: Kaveh Ardalan; Oluwatosin Adeyemi; Dawn M Wahezi; Anne E Caliendo; Megan L Curran; Jessica Neely; Susan Kim; Colleen K Correll; Emily J Brunner; Andrea M Knight Journal: Arthritis Care Res (Hoboken) Date: 2020-11-27 Impact factor: 4.794
Authors: Matteo Catanzano; Sophie D Bennett; Ellie Kerry; Holan Liang; Isobel Heyman; Anna E Coughtrey; Kate Fifield; Chloe Taylor; Tim Dalgleish; Laila Xu; Roz Shafran Journal: Evid Based Ment Health Date: 2020-11-26